 Morgan Stanley boosted its position in Integra Lifesciences Holdings Corp NASDAQ:IART by 202.9 in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The fund owned 376,781 shares of the life sciences companys stock after buying an additional 252,381 shares during the quarter. Morgan ... 